SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CareDx, Inc. – CDNA

NEW YORK, July 09, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CareDx, Inc. ("CareDx" or the "Company") (NASDAQ: CDNA).   Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether CareDx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On October 28, 2021, CareDx filed its quarterly report for the third quarter of 2021 on Form 10-Q with the U.S. Securities and Exchange Commission ("SEC").  In the quarterly report, CareDx revealed for the first time that CareDx was the subject of at least three government investigations, reporting that: (1) the Company had "recently received" a civil investigative demand ("CID") from the U.S. Department of Justice ("DOJ") requesting the Company produce documents in ... Full story available on Benzinga.com